Danish drugmaker Novo Nordisk (NOVOb.CO) said on Wednesday it was disappointed with the recommendation to the Netherlands government to not cover its hugely popular weight-loss drug Wegovy under the country's basic insurance.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,